The 2024 Beauty Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Beauty care industry, today ...
The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...
Results that may be inaccessible to you are currently showing.